ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 143

$861K Total Retail Price of All Prescriptions

Rank: 5 out of 143

449 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,694 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
PRAVASTATIN SODIUM 406 304 1 9
LISINOPRIL 368 286 2 1
SIMVASTATIN 355 298 3 2
LEVOTHYROXINE SODIUM 310 253 4 3
ATORVASTATIN CALCIUM 303 245 5 7
FUROSEMIDE 298 247 6 6
AMLODIPINE BESYLATE 246 183 7 4
DONEPEZIL HCL 215 213 8 36
HYDROCODONE-ACETAMINOPHEN 210 145 S3 9 20
METOPROLOL SUCCINATE 201 176 10 14
METFORMIN HCL 193 143 11 8
CLOPIDOGREL 192 142 12 33
METOPROLOL TARTRATE 191 160 13 12
OMEPRAZOLE 191 125 13 5
CRESTOR 190 147 15 17
CITALOPRAM HBR 175 137 16 25
HYDROCHLOROTHIAZIDE 144 119 17 10
ZOLPIDEM TARTRATE 143 41 18 13
BISOPROLOL FUMARATE 143 113 18 67
OXYCODONE HCL 141 42 S2 20 29
NAMENDA 141 141 20 49
ATENOLOL 127 104 22 11
PLAVIX 127 91 22 51
GABAPENTIN 122 81 24 18
WARFARIN SODIUM 117 86 25 15
FENOFIBRATE 116 75 26 109
AZITHROMYCIN 111 64 27 31
CARVEDILOL 107 93 28 22
GLIMEPIRIDE 106 62 29 27
AMLODIPINE BESYLATE-BENAZEPRIL 105 94 30 84
CIPROFLOXACIN HCL 104 85 31 58
TRAMADOL HCL 103 95 32 16
ISOSORBIDE MONONITRATE ER 102 83 33 44
LOSARTAN POTASSIUM 102 64 33 19
PANTOPRAZOLE SODIUM 101 91 35 43
PREDNISONE 99 57 36 35
SYNTHROID 99 92 36 24
KLOR-CON M20 97 64 38 69
TRICOR 96 40 39 71
POTASSIUM CHLORIDE 92 72 40 34
RANITIDINE HCL 91 43 41 41
ENALAPRIL MALEATE 91 87 41 114
MIRTAZAPINE 87 63 43 30
LEVOFLOXACIN 84 58 44 68
HYDRALAZINE HCL 79 46 45 64
CARBIDOPA-LEVODOPA 77 77 46 93
MORPHINE SULFATE 77 21 S2 46 187
CYCLOBENZAPRINE HCL 77 34 R 46 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 44 49 21
ALLOPURINOL 73 61 50 39
LOVASTATIN 73 69 50 50
MELOXICAM 71 61 52 78
OXYCODONE-ACETAMINOPHEN 70 21 S2 53 56
NEXIUM 69 46 54 32
LIPITOR 67 54 55 57
TAMSULOSIN HCL 63 51 56 28
POLYETHYLENE GLYCOL 3350 62 60 57 45
DIOVAN 62 54 57 26
FLUOXETINE HCL 61 34 59 101
ESCITALOPRAM OXALATE 56 48 60 46
TRAZODONE HCL 55 47 61 59
OXYBUTYNIN CHLORIDE 53 42 62 215
MORPHINE SULFATE ER 52 25 S2 63 144
NOVOLOG MIX 70-30 FLEXPEN 51 36 64 133
ADVAIR DISKUS 50 15 65 42
GLIPIZIDE 50 46 65 55
OXYCODONE HCL-ACETAMINOPHEN 50 19 S2 65 73
SPIRONOLACTONE 50 45 65 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.